Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

171
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
171

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acrylate Copolymers/Crosspolymers in Sunscreens: Minimally Allergenic, Without Evidence of Need for Avoidance by (Meth)Acrylate-Sensitized Individuals.

Contact dermatitis·2026
Same author

Analysis of Sulfite Concentrations in Common Beverages Consumed in the United States.

Dermatitis : contact, atopic, occupational, drug·2026
Same author

Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary.

The Journal of dermatological treatment·2026
Same author

Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis.

Dermatology and therapy·2026
Same author

Long-term efficacy of abrocitinib in patients with moderate-to-severe atopic dermatitis to 2 years.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

The Long-Term Impact of Childhood and Adolescent Atopic Dermatitis on Physical and Psychosocial Well-Being: Scars of Life project.

Clinical and experimental dermatology·2026

Related Experiment Video

Updated: Apr 11, 2026

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

8.4K

North American Contact Dermatitis Group Patch Test Results: 2021-2022.

Marie-Claude Houle1, Joel G DeKoven2, Amber Reck Atwater3

  • 1From the Division of Dermatology, Centre Hospitalier Universitaire Québec, Laval University, Québec, Canada.

Dermatitis : Contact, Atopic, Occupational, Drug
|April 24, 2025
PubMed
Summary
This summary is machine-generated.

Patch testing for allergic contact dermatitis (ACD) revealed increasing nickel and cobalt allergies, while methylisothiazolinone (MI) allergy prevalence declined. Many patients reacted to allergens not in the standard screening series.

More Related Videos

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

2.5K
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

3.1K

Related Experiment Videos

Last Updated: Apr 11, 2026

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

8.4K
Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

2.5K
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

3.1K

Area of Science:

  • Dermatology
  • Allergology
  • Epidemiology

Background:

  • Patch testing is crucial for diagnosing allergic contact dermatitis (ACD).
  • The North American Contact Dermatitis Group (NACDG) collects data on patch testing results.
  • Understanding current allergen prevalence is vital for clinical practice and public health.

Purpose of the Study:

  • To report NACDG patch testing results from 2021-2022.
  • To identify common allergens and trends in ACD.
  • To assess the prevalence of reactions to allergens outside the standard screening series.

Main Methods:

  • Standardized patch testing with an 80-allergen screening series was performed at 12 North American centers.
  • Data from 3056 patients tested between 2021 and 2022 were analyzed.
  • Statistical comparisons were made with previous NACDG data (2019-2020).

Main Results:

  • 72.0% of patients had at least one positive patch test reaction; 46.6% were diagnosed with ACD.
  • Most common allergens: nickel sulfate (24.9%), MI (11.5%), hydroperoxides of linalool (10.1%), cobalt chloride (9.2%).
  • Statistically significant increases in prevalence were observed for nickel, cobalt, gold, hydroperoxides of limonene, and others compared to 2019-2020. MI positivity continued to decrease.
  • 21.1% of patients reacted to allergens not included in the standard screening series.

Conclusions:

  • The prevalence of methylisothiazolinone (MI) contact allergy in North America is decreasing.
  • Fragrance allergies remain common, but the specific allergens involved are shifting.
  • Comprehensive patch testing, including supplemental allergens, is essential for evaluating ACD effectively.